AstraZeneca Pharma India appoints Vinay Sharma as enterprise unit head 

AstraZeneca Pharma India Ltd. has appointed Vinay Sharma as Enterprise Unit Head of Uncommon Illness, with impact from July 1, 2024.

Presently, Sharma is part of the Philippines nation management workforce because the enterprise unit head, Respiratory and Immunology.

Based on the inventory change disclosure, Vinay Sharma is a publish‐graduate in advertising and marketing administration and enterprise administration with over 23 years of business expertise.

• Additionally learn: Karnataka and AstraZeneca collaborate to display screen for lung ailments together with most cancers

He joined AstraZeneca India in 2013 as Advertising Supervisor of Diabetes. During the last decade, he has held a number of management positions in gross sales, advertising and marketing, and affected person advocacy management, in AstraZeneca India and different worldwide markets.

He has been instrumental in main the launch of Forxiga in India, the disclosure said.

AstraZeneca Pharma India shares closed greater by 1.37 per cent on the NSE at ₹5,100 on Friday’s commerce.